[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353174-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353174-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","porphyrin-lipid-nanotheranostics-for-multimodal-imaging-of-nodal-disease-in-preclinical-oral-cancers","Porphyrin-lipid nanotheranostics for multimodal imaging of nodal disease in preclinical oral cancers","","Porphyrin-lipid nanotheranostics are evaluated to improve detection of microscopic cervical lymph node disease in preclinical oral cancer models. The study addresses the clinical limitation of standard imaging in clinically negative neck nodes with microscopic metastases. Xenograft tongue cancer models receive Copper-64 labeled porphyrin-lipid nanoparticles via imaging-compatible routes, enabling serial PET/MR and endpoint fluorescence imaging and comparison with 18F-FDG PET and pathological staging for predictive performance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/porphyrin-lipid-nanotheranostics-for-multimodal-imaging-of-nodal-disease-in-preclinical-oral-cancers/353174/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/porphyrin-lipid-nanotheranostics-for-multimodal-imaging-of-nodal-disease-in-preclinical-oral-cancers/353174.png","ImageObject",300,407,{"name":42,"@type":43},"Kurz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are cervical lymph node metastases important in oral cancer?","Question",{"text":63,"@type":64},"Cervical lymph node metastases are frequent in oral cancer patients and are a key prognostic factor for disease outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the study detect nodal disease in preclinical models?",{"text":68,"@type":64},"It uses Copper-64 labeled porphyrin-lipid nanoparticles for multimodal detection, combining serial PET/MR imaging with endpoint fluorescence imaging, then compares results with pathological staging.",{"name":70,"@type":61,"acceptedAnswer":71},"How did 64Cu-PS PET and fluorescence imaging compare in identifying metastatic nodes?",{"text":72,"@type":64},"Fluorescence imaging provided the best prediction metrics (including highest sensitivity and predictive performance), while 64Cu-PS PET performed slightly worse than fluorescence but better than 18F-FDG PET.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353174,1790668963,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Theranostics 2026, Vol. 16, Issue 13 7108  \nIvyspring  \nInternational Publisher  \nTheranostics  \n2026; 16(13): 7108-7123. doi: 10.7150/thno.129853  \nResearch Paper  \nPorphyrin-lipid nanotheranostics for multimodal imaging of nodal disease in preclinical oral cancers  \nMichael S. Valic1,2, Esmat Najjar1,3,4, Mark Zheng1, Jason L. Townson1,3, Harley H. L. Chan1,3, Sharon Tzelnick1,3,4, Alessandra Ruaro1,3,4, Abdullah El-Sayes1, Michael Halim1, Pamela Schimmer1, Chris J. Zhang1, Tina Ye1, Wenlei Jiang1, Juan Chen1, Jonathan C. Irish1,3,4􀀍, Gang Zheng1,2,5􀀍  \n1. Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.  \n2. Institute of Biomedical Engineering, Faculty of Applied Science and Engineering, University of Toronto, Toronto, Canada.  \n3. Guided Therapeutics Program, University Health Network, Toronto, Canada.  \n4. Department of Otolaryngology–Head and Neck Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.  \n5. Department of Medical Biophysics, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.  \n􀀍 Corresponding authors: Jonathan C. Irish, Princess Margaret Cancer Centre, University Health Network, 200 Elizabeth Street, 8NU-882, Toronto, ON M5G 2C4, [Canada. E-mail: jonathan.irish@uhn.ca. Gang Zheng](Canada. E-mail: jonathan.irish@uhn.ca. Gang Zheng), Princess Margaret Cancer Centre, University Health Network, 101 College Street, PMCRT RM 5-354, Toronto, ON M5G 1L7, Canada. Phone: 416-581-7667; [E-mail: gang.zheng@uhn.ca](E-mail: gang.zheng@uhn.ca).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.12.12; Accepted: 2026.05.20; Published: 2026.05.29  \nAbstract  \nRationale: Cervical lymph node metastases in oral cancer patients are a frequent occurrence and important prognostic factor. Anatomical and molecular imaging modalities can identify neck metastases with varying sensitivity and specificity but perform poorly in clinically negative neck nodes with microscopic disease. Herein we investigate the use of porphyrin-lipid nanotheranostics (PS) for multimodal detection of neck disease in preclinical models of oral cancer.  \nMethods: Xenograft models of tongue cancer were established in nude rats using MOC2 mouse oral squamous cells. PS nanoparticles were radiolabelled with positron-emitting Copper-64 (64Cu-PS) and administered either IT (100 MBq 64Cu, 0.5 mg) or IV (250–500 MBq 64Cu/kg, 0.5–1.0 mg/kg). Uptake in the tumour and cervical lymph nodes was measured with serial PET/MR imaging and at endpoint with in situ fluorescence (FL) imaging. In the IV cohort, 64Cu-PS uptake was compared to 18F-FDG (46 MBq 18F/kg) PET performed prior to nanoparticle injection. After imaging, neck nodes were harvested for pathological staging. Receiver operating characteristics were compared in the IV cohort between 18F-FDG vs 64Cu-PS PET imaging vs FL imaging.  \nResults: The tongue tumour model yielded micrometastases to 54% of neck nodes by 14 d post-implantation. Following IT injection, sentinel and metastatic lymph nodes were visible with 64Cu-PS PET for 72 h. Following IV injection, 64Cu-PS PET signal in the tumour and neck nodes was clearest at 24 h and significant differences in the pooled SUVs of benign vs metastatic nodes were obtained. On FL imaging, metastatic neck nodes had significantly higher fluorescent signal (S/B) compared to benign nodes. Overall, FL S/Bmean gave the best prediction of nodal disease with 75% SEN, 79% SPC, and 71% NPV. 64Cu-PS PET (SUVmax: 77% SEN, 68% SPC, 68% NPV) performed slightly worse than FL imaging for identifying metastatic nodes but still better compared to 18F-FDG PET (SUVmax: 81% SEN, 43% SPC, 59% NPV). Inflamed nodes were the commonest source of false positiv","cbCaiciTYQcyc9Rc","https://ap.wps.com/l/cbCaiciTYQcyc9Rc","pdf",13113598,16,"English","# Abstract\n## Rationale\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"Why are cervical lymph node metastases important in oral cancer?\",\"answer\":\"Cervical lymph node metastases are frequent in oral cancer patients and are a key prognostic factor for disease outcomes.\"},{\"question\":\"How does the study detect nodal disease in preclinical models?\",\"answer\":\"It uses Copper-64 labeled porphyrin-lipid nanoparticles for multimodal detection, combining serial PET/MR imaging with endpoint fluorescence imaging, then compares results with pathological staging.\"},{\"question\":\"How did 64Cu-PS PET and fluorescence imaging compare in identifying metastatic nodes?\",\"answer\":\"Fluorescence imaging provided the best prediction metrics (including highest sensitivity and predictive performance), while 64Cu-PS PET performed slightly worse than fluorescence but better than 18F-FDG PET.\"}]","Porphyrin-lipid nanotheranostics for multimodal imaging of nodal disease in preclinical oral cancers | PDF",1790103419,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1290b10572075457a285c2877944075.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c458ec87b2f30a8534a914a3a5f03ed1.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73a4ee711ecf1db599619a13aaea33fd.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88f55289b01e1ea1213d8ca3a0eeb9b8.webp",980,1268]